InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Santos David A, 董事. Officer active across 1 company, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 11 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €57k. Activity tracked since 24 January 2022. The latest transaction was disclosed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Santos David A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
874 股@ US$47.50Common StockSEC:0000905148-26-004079:0
19,430 股0Common StockSEC:0000905148-26-000954:0
3,546 股@ US$34.6230.9% 占其流量Common StockSEC:0000905148-26-000679:0
5,718 股@ US$36.0152.0% 占其流量Common StockSEC:0000905148-26-000498:0
2,125 股@ US$20.92175.5% 占其流量Common StockSEC:0000905148-25-000412:0
19,717 股0Common StockSEC:0000905148-25-000299:0
5,601 股@ US$1.1310.2% 占其流量Common StockSEC:0000905148-24-000447:0
209,000 股0Common StockSEC:0000905148-24-000307:0
5,388 股@ US$1.660214.3% 占其流量Common StockSEC:0001140361-23-004733:0
80,000 股0Common StockSEC:0001140361-23-003439:0
50,000 股0Common StockSEC:0001567619-22-001780:0
11 条申报中的 11 条
About Santos David A
Santos David A is Administrateur and EVP, Chief Commercial Officer at RIGEL PHARMACEUTICALS INC (XNAS). He has 10 filings in total, and across the 10 sampled recent filings, sales total EUR 56990 and the period runs from 2022-01-26 to 2026-02-19, with modal transaction nature listed as Attribution.
